Idiopathic Granulomatous Mastitis in India: Imaging Spectrum and Outcomes across Different Management Strategies [0.03%]
印度特发性肉芽肿性乳腺炎的影像学特征及不同治疗策略的效果
Shiveta Razdan,Adhrit Jha,Megha Tandon et al.
Shiveta Razdan et al.
Introduction: Idiopathic granulomatous mastitis (IGM) is a benign inflammatory breast condition that frequently mimics carcinoma, posing significant diagnostic and therapeutic challenges. In tuberculosis-endemic regions, ...
Assessing Patient Satisfaction with Mammography Using Patient-Reported Measures: A Prospective Observational Study [0.03%]
基于患者报告的测量评估乳腺X线摄影患者的满意度：前瞻性队列研究
Gaia Garuffi,Dirk Lehnick,Gioia Fischer et al.
Gaia Garuffi et al.
Introduction: Negative experiences during mammography can reduce patient's adherence. Yet patient-reported measures focusing on the diagnostic pathway remain limited, particularly in general radiology departments that are...
Comprehensive Liquid Biopsy Testing in Metastatic Hormone Receptor-Positive HER2-Negative Breast Cancer Patients: First Results from Routine Clinical Practice [0.03%]
转移性激素受体阳性HER2阴性乳腺癌患者的全面液体活检检测——来自常规临床实践的初步结果
Karsten M Warwas,Anna-Lena Volckmar,Daniel Kazdal et al.
Karsten M Warwas et al.
Introduction: Liquid biopsy (LBx) is a minimally invasive diagnostic approach that allows molecular profiling of circulating tumor DNA. In hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2)-ne...
Differences in Biomarkers between the Primary Tumor and Axillary Lymph Nodes in Invasive Lobular Carcinoma: A Retrospective Study [0.03%]
浸润性小叶癌原发灶与腋窝淋巴结生物标志物差异的回顾性研究
Caglar Kazim Pekuz,Mahmut Zenciroglu,Serdar Basim et al.
Caglar Kazim Pekuz et al.
Introduction: Invasive lobular carcinoma (ILC) is a distinct histological subtype of breast cancer characterized by hormone receptor positivity, low proliferative activity, and unique metastatic patterns. However, recent ...
Impact of Synchronous B3 Lesions on Clinicopathological Data and Prognosis in Patients with Breast Cancer [0.03%]
同步B3期病变对乳腺癌患者临床病理特征及预后的影响
Eray Balci,Ersin Turan,Hande Koksal
Eray Balci
Introduction: Breast cancer is a significant disease as it is the most frequently diagnosed cancer and the leading cause of cancer-related mortality among women. The factors affecting the prognosis of breast cancer are re...
Breast-Conserving Surgery in Multicentric Breast Cancer: Progress, Pitfalls, and Risks [0.03%]
多中心乳腺癌的保乳手术：进展、陷阱和风险
Isabell Witzel
Isabell Witzel
Expanding the Boundaries of Breast Conservation: Oncoplastic Surgery in Multifocal and Multicentric Breast Cancer [0.03%]
乳腺癌多中心或多灶性疾病保乳手术的扩大适应证：肿瘤整形外科的应用与发展
Mehmet Furkan Sağdıç,Mahmut Onur Kültüroğlu,Emre Tunç et al.
Mehmet Furkan Sağdıç et al.
Introduction: The development of oncoplastic surgical techniques has reshaped the management of multifocal and multicentric breast cancers. Previously treated mainly with mastectomy due to concerns about positive margins ...
Lisa Jung,Markus Medl,Hannes Endres et al.
Lisa Jung et al.
Introduction: Staging examinations have historically not been standard practice in low-risk early breast cancer (EBC). This study aimed to assess the frequency, modalities, and clinical implications of staging diagnostics...
Next-Generation CDK Inhibitors in Breast Cancer: Expanding the Therapeutic Landscape beyond CDK4/6 Inhibitors [0.03%]
下一代CDK抑制剂在乳腺癌中的应用：超越CDK4/6抑制剂拓展治疗格局
Jiayi Wu,Yinglu Lai,Guang Lu
Jiayi Wu
Background: The efficacy of CDK4/6 inhibitors in hormone receptor-positive breast cancer has catalyzed the exploration of other cyclin-dependent kinases (CDKs) as therapeutic targets. Numerous CDK family members are aberr...
Pre-Pectoral Breast Reconstruction after Mastectomy: Current Evidence, Knowledge Gaps, and Rationale for the I-PREPARE EUBREAST-11R Trial [0.03%]
乳房切除术后前胸大肌乳腺重建：当前证据、知识空白及I-PREPARE EUBREAST-11R试验合理性分析
Rosa Di Micco,Lorenzo Scardina,Edoardo Botteri et al.
Rosa Di Micco et al.
Introduction: Pre-pectoral implant-based breast reconstruction (IBR) has emerged as a promising alternative to conventional subpectoral approaches following nipple- or skin-sparing mastectomy. However, long-term oncologic...